I

Inter Pharma PCL
SET:IP

Watchlist Manager
Inter Pharma PCL
SET:IP
Watchlist
Price: 4.6 THB 3.6%
Market Cap: 2.8B THB
Section:
 

Relative Value

The Relative Value of one IP stock under the Base Case scenario is hidden THB. Compared to the current market price of 4.6 THB, Inter Pharma PCL is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IP Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

1.4
P/S
P/S
Price to Sales
1.4
vs History
74
vs Industry
Median 3Y
1.6
Median 5Y
2.1
Industry
1.1
More Details
38.8
P/E
P/E
Price to Earnings
38.8
vs History
53
vs Industry
Median 3Y
39.6
Median 5Y
38
Industry
17.9
More Details
11.7
P/OCF
P/OCF
Price to OCF
11.7
vs History
55
vs Industry
Median 3Y
15.8
Median 5Y
15.1
Industry
11.8
More Details
113.2
P/FCFE
P/FCFE
Price to FCFE
113.2
vs History
14
vs Industry
Median 3Y
-9.2
Median 5Y
13.4
Industry
15.5
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
71
vs Industry
Median 3Y
1.4
Median 5Y
1.8
Industry
1.6
More Details
1.5
EV/S
EV/S
Enterprise Value to Sales
1.5
vs History
69
vs Industry
Median 3Y
1.5
Median 5Y
2
Industry
1.2
More Details
3.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.9
vs History
71
vs Industry
Median 3Y
4.1
Median 5Y
4.9
Industry
3.9
More Details
13.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.2
vs History
66
vs Industry
Median 3Y
12.6
Median 5Y
15.5
Industry
10.6
More Details
25
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
25
vs History
49
vs Industry
Median 3Y
23.3
Median 5Y
23.5
Industry
13.7
More Details
13.1
EV/OCF
EV/OCF
Enterprise Value to OCF
13.1
vs History
55
vs Industry
Median 3Y
17.4
Median 5Y
13.9
Industry
12.6
More Details
1 562
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
1 562
vs History
0
vs Industry
Median 3Y
23.1
Median 5Y
-19.6
Industry
15.6
More Details
1.1
EV/IC
EV/IC
Enterprise Value to IC
1.1
vs History
73
vs Industry
Median 3Y
1.2
Median 5Y
1.5
Industry
1.2
More Details

Multiples Across Competitors

IP Competitors Multiples
Inter Pharma PCL Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
TH
Inter Pharma PCL
SET:IP
2.8B THB 1.4 38.8 13.2 25
FR
L'Oreal SA
PAR:OR
199.8B EUR 4.6 32.6 18.9 23
UK
Unilever PLC
LSE:ULVR
119.6B GBP 2.3 23.8 202.9 235.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.3T INR 8.3 49.1 35.6 39.4
UK
HALEON PLC
LSE:HLN
33.4B GBP 3 23.1 13.9 15.9
US
Estee Lauder Companies Inc
NYSE:EL
37.7B USD 2.6 -41 20.6 34
DE
Beiersdorf AG
XETRA:BEI
20.6B EUR 2.1 23.4 11.5 14.7
JP
Kao Corp
TSE:4452
2.9T JPY 1.7 23.6 11.2 17.3
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.2T INR 8.1 66.2 41.1 45.1
MY
Bioalpha Holdings Bhd
KLSE:BIOHLDG
39.4B MYR 1 552.9 -927.2 -1 644.9 -1 246.9
IN
Dabur India Ltd
NSE:DABUR
875.8B INR 6.9 48.4 36.3 44.9
P/E Multiple
Earnings Growth PEG
TH
I
Inter Pharma PCL
SET:IP
Average P/E: 36.6
38.8
N/A N/A
FR
L'Oreal SA
PAR:OR
32.6
8%
4.1
UK
Unilever PLC
LSE:ULVR
23.8
13%
1.8
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
49.1
8%
6.1
UK
HALEON PLC
LSE:HLN
23.1
12%
1.9
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -41 N/A N/A
DE
Beiersdorf AG
XETRA:BEI
23.4
8%
2.9
JP
Kao Corp
TSE:4452
23.6
12%
2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
66.2
19%
3.5
MY
B
Bioalpha Holdings Bhd
KLSE:BIOHLDG
Negative Multiple: -927.2 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
48.4
12%
4
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
TH
I
Inter Pharma PCL
SET:IP
Average EV/EBITDA: 40.5
13.2
N/A N/A
FR
L'Oreal SA
PAR:OR
18.9
5%
3.8
UK
Unilever PLC
LSE:ULVR
202.9
2%
101.4
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
35.6
8%
4.5
UK
HALEON PLC
LSE:HLN
13.9
4%
3.5
US
Estee Lauder Companies Inc
NYSE:EL
20.6
15%
1.4
DE
Beiersdorf AG
XETRA:BEI
11.5
-1%
N/A
JP
Kao Corp
TSE:4452
11.2
8%
1.4
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
41.1
13%
3.2
MY
B
Bioalpha Holdings Bhd
KLSE:BIOHLDG
Negative Multiple: -1 644.9 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
36.3
11%
3.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
TH
I
Inter Pharma PCL
SET:IP
Average EV/EBIT: 49.5
25
N/A N/A
FR
L'Oreal SA
PAR:OR
23
6%
3.8
UK
Unilever PLC
LSE:ULVR
235.7
2%
117.8
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
39.4
9%
4.4
UK
HALEON PLC
LSE:HLN
15.9
4%
4
US
Estee Lauder Companies Inc
NYSE:EL
34
25%
1.4
DE
Beiersdorf AG
XETRA:BEI
14.7
-1%
N/A
JP
Kao Corp
TSE:4452
17.3
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
45.1
13%
3.5
MY
B
Bioalpha Holdings Bhd
KLSE:BIOHLDG
Negative Multiple: -1 246.9 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
44.9
11%
4.1

See Also

Summary
IP intrinsic value, competitors valuation, and company profile.
DCF Valuation
IP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IP stock valuation using valuation multiples.
Wall Street Estimates
IP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 303,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.